rs13023213

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001145873.1(CD8A):​c.-270-3725A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.194 in 152,148 control chromosomes in the GnomAD database, including 3,121 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.19 ( 3121 hom., cov: 32)

Consequence

CD8A
NM_001145873.1 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.566

Publications

10 publications found
Variant links:
Genes affected
CD8A (HGNC:1706): (CD8 subunit alpha) The CD8 antigen is a cell surface glycoprotein found on most cytotoxic T lymphocytes that mediates efficient cell-cell interactions within the immune system. The CD8 antigen acts as a coreceptor with the T-cell receptor on the T lymphocyte to recognize antigens displayed by an antigen presenting cell in the context of class I MHC molecules. The coreceptor functions as either a homodimer composed of two alpha chains or as a heterodimer composed of one alpha and one beta chain. Both alpha and beta chains share significant homology to immunoglobulin variable light chains. This gene encodes the CD8 alpha chain. Multiple transcript variants encoding different isoforms have been found for this gene. The major protein isoforms of this gene differ by the presence or absence of a transmembrane domain and thus differ in being a membrane-anchored or secreted protein. [provided by RefSeq, May 2020]
CD8A Gene-Disease associations (from GenCC):
  • susceptibility to respiratory infections associated with CD8alpha chain mutation
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, ClinGen, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.251 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001145873.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CD8A
NM_001145873.1
c.-270-3725A>G
intron
N/ANP_001139345.1Q6ZVS2
CD8A
NM_001382698.1
c.-270-3725A>G
intron
N/ANP_001369627.1P01732-1
CD8A
NR_168478.1
n.744-3154A>G
intron
N/A

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CD8A
ENST00000409511.6
TSL:2
c.-270-3725A>G
intron
N/AENSP00000386559.2P01732-1
CD8A
ENST00000699439.1
c.-270-3725A>G
intron
N/AENSP00000514390.1P01732-2
CD8A
ENST00000699437.1
n.343-6260A>G
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.194
AC:
29441
AN:
152030
Hom.:
3118
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.150
Gnomad AMI
AF:
0.266
Gnomad AMR
AF:
0.135
Gnomad ASJ
AF:
0.192
Gnomad EAS
AF:
0.0692
Gnomad SAS
AF:
0.0635
Gnomad FIN
AF:
0.171
Gnomad MID
AF:
0.218
Gnomad NFE
AF:
0.255
Gnomad OTH
AF:
0.187
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.194
AC:
29460
AN:
152148
Hom.:
3121
Cov.:
32
AF XY:
0.186
AC XY:
13864
AN XY:
74376
show subpopulations
African (AFR)
AF:
0.151
AC:
6249
AN:
41518
American (AMR)
AF:
0.135
AC:
2059
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.192
AC:
667
AN:
3470
East Asian (EAS)
AF:
0.0692
AC:
358
AN:
5176
South Asian (SAS)
AF:
0.0644
AC:
311
AN:
4828
European-Finnish (FIN)
AF:
0.171
AC:
1816
AN:
10594
Middle Eastern (MID)
AF:
0.214
AC:
63
AN:
294
European-Non Finnish (NFE)
AF:
0.255
AC:
17301
AN:
67968
Other (OTH)
AF:
0.186
AC:
393
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1175
2350
3525
4700
5875
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
304
608
912
1216
1520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.212
Hom.:
773
Bravo
AF:
0.189
Asia WGS
AF:
0.0820
AC:
285
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.69
DANN
Benign
0.34
PhyloP100
-0.57
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs13023213; hg19: chr2-87021943; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.